Co-Authors
This is a "connection" page, showing publications co-authored by Ahmed Kandeil and Mohamed Ali.
Connection Strength
2.045
-
Bioactive Polyphenolic Compounds Showing Strong Antiviral Activities against Severe Acute Respiratory Syndrome Coronavirus 2. Pathogens. 2021 Jun 15; 10(6).
Score: 0.951
-
FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2. Pharmaceuticals (Basel). 2020 Dec 04; 13(12).
Score: 0.229
-
Middle East Respiratory Syndrome Coronavirus (MERS-CoV): State of the Science. Microorganisms. 2020 Jul 02; 8(7).
Score: 0.223
-
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East. Viruses. 2019 08 05; 11(8).
Score: 0.209
-
Systematic, active surveillance for Middle East respiratory syndrome coronavirus in camels in Egypt. Emerg Microbes Infect. 2017 Jan 04; 6(1):e1.
Score: 0.175
-
Complete Genome Sequence of Middle East Respiratory Syndrome Coronavirus Isolated from a Dromedary Camel in Egypt. Genome Announc. 2016 Apr 28; 4(2).
Score: 0.167
-
Bacterial Outer Membrane Vesicles (OMVs)-based Dual Vaccine for Influenza A H1N1 Virus and MERS-CoV. Vaccines (Basel). 2019 05 28; 7(2).
Score: 0.052
-
Surveillance for Coronaviruses in Bats, Lebanon and Egypt, 2013-2015. Emerg Infect Dis. 2016 Jan; 22(1):148-50.
Score: 0.041